The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BNTX FINANCIAL STATEMENTS

BioNTech SE — balance sheet, income statement and cash flow trends

BNTXBioNTech SE

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
010 B20 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue2.6 B €Gross Profit1.7 B € · 64%Operating Income-1.7 B € · -64%Pre-tax Income-1.7 B € · -62%Net Income to Owners-1.7 B € · -64%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue2.6 B €-8.1%
Gross Profit1.7 B €-25.9%
Operating Income-1.7 B €—
EBITDA-838.3 M €—
Net Income to Owners-1.7 B €—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
010 B20 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets20.3 B
  • Equity17.8 B €87%
  • Current Liabilities1.9 B €10%
  • Long-term Liabilities635.6 M €3%

Key Figures

YoY change
Total Assets20.3 B €-6.0%
Total Liabilities2.6 B €-17.5%
Total Equity17.8 B €-4.1%
Cash & ST Investments9.7 B €-30.6%
Total Debt316 M €+17.2%
Net Debt-9.4 B €—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
05 B10 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0500 M736.8 M €Operating-1 B €Investing-112.1 M €Financing-407.6 M €Net Change

Key Figures

YoY change
Operating Cash Flow736.8 M €—
Capital Expenditures218.5 M €-84.5%
Free Cash Flow518.3 M €—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BNTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.